NewGenIvf Group Limited (NASDAQ:NIVF) Short Interest Update

NewGenIvf Group Limited (NASDAQ:NIVF) was the recipient of a large decrease in short interest in the month of August. As of August 31st, there was short interest totaling 91,719 shares, a decrease of 46.6% from the August 15th total of 171,641 shares. Based on an average daily volume of 672,683 shares, the short-interest ratio is currently 0.1 days. Approximately 6.4% of the shares of the company are short sold.

Analysts Set New Price Targets

Several research firms recently weighed in on NIVF. Weiss Ratings reiterated a “sell (d)” rating on shares of NewGenIvf Group in a research note on Friday, July 24th. Wall Street Zen upgraded NewGenIvf Group to a “hold” rating in a research note on Saturday, July 4th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, NewGenIvf Group presently has an average rating of “Sell”.

NewGenIvf Group Stock Performance

NIVF traded down $0.09 during trading on Tuesday, reaching $0.84. 177,620 shares of the company’s stock were exchanged, compared to its average volume of 283,998. The company has a quick ratio of 2.98, a current ratio of 3.12 and a debt-to-equity ratio of 0.16. The business has a 50 day moving average price of $2.29 and a 200 day moving average price of $9.56. NewGenIvf Group has a fifty-two week low of $0.81 and a fifty-two week high of $1,539.00.

Insider Transactions at NewGenIvf Group

In related news, Director Kong Yiu Cheung purchased 2,500,000 shares of the firm’s stock in a transaction on Monday, July 27th. The shares were bought at an average cost of $1.00 per share, for a total transaction of $2,500,000.00. Following the transaction, the director directly owned 3,722,223 shares of the company’s stock, valued at approximately $3,722,223. This trade represents a 204.55% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 31.80% of the stock is owned by corporate insiders.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.